Journal of International Oncology››2020,Vol. 47››Issue (1): 43-45.doi:10.3760/cma.j.issn.1673-422X.2020.01.008
• Reviews •Previous ArticlesNext Articles
Received:
2019-11-22Revised:
2019-12-08Online:
2020-01-08Published:
2020-03-22Contact:
Chen Bo E-mail:chenbo831116@163.comSupported by:
Xu Xin, Chen Bo. Application and new progress of enhanced recovery after surgery in perioperative period of gastric cancer patients[J]. Journal of International Oncology, 2020, 47(1): 43-45.
[1] | Ruiz-Tovar J, Garcia A, Ferrigni C , et al. Impact of implementation of an enhanced recovery after surgery (ERAS) program in laparoscopic Roux-en-Y gastric bypass: a prospective randomized clinical trial[J]. Surg Obes Relat Dis, 2019,15(2):228-235. DOI: 10.1016/j.soard.2018.11.002. |
[2] | Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E , et al. Guidelines for enhanced recovery after lung surgery: recommendations of the enhanced recovery after surgery (ERAS®) society and the European society of thoracic surgeons (ESTS) [J]. Eur J Cardiothorac Surg, 2019,55(1):91-115. DOI: 10.1093/ejcts/ezy301. |
[3] | Low DE, Allum W, De Manzoni G , et al. Guidelines for perioperative care in esophagectomy: enhanced recovery after surgery (ERAS®) society recommendations [J]. World J Surg, 2019,43(2):299-330. DOI: 10.1007/s00268-018-4786-4. |
[4] | Desiderio J, Stewart CL, Sun V , et al. Enhanced recovery after surgery for gastric cancer patients improves clinical outcomes at a US cancer center[J]. J Gastric Cancer, 2018,18(3):230-241. DOI: 10.5230/jgc.2018.18.e24. |
[5] | Mortensen K, Nilsson M, Slim K , et al. Consensus guidelines for enhanced recovery after gastrectomy: enhanced recovery after surgery (ERAS®) society recommendations [J]. Br J Surg, 2014,101(10):1209-1229. DOI: 10.1002/bjs.9582. |
[6] | 中国研究型医院学会机器人与腹腔镜外科专业委员会. 胃癌胃切除手术加速康复外科专家共识(2016版)[J]. 中华消化外科杂志, 2017,16(1):14-17. DOI: 10.3760/cma.j.issn.1673-9752.2017.01.003. |
[7] | 中华医学会外科学分会, 中华医学会麻醉学分会. 加速康复外科中国专家共识及路径管理指南(2018版)[J]. 中国实用外科杂志, 2018,38(1):1-20. DOI: 10.19538/j.cjps.issn1005-2208.2018.01.01. |
[8] | Jeong O, Park YK, Jung MR , et al. Compliance with guidelines of enhanced recovery after surgery in elderly patients undergoing gastrectomy[J]. World J Surg, 2017,41(4):1040-1046. DOI: 10.1007/s00268-016-3845-y. |
[9] | Zhao J, Hu J, Jiang Z , et al. Outcome of discharge within 72 hours of robotic gastrectomy using enhanced recovery after surgery programs[J]. J Laparoendosc Adv Surg Tech A, 2018,28(11):1279-1286. DOI: 10.1089/lap.2018.0051. |
[10] | Zhao J, Wang G, Jiang ZW , et al. Patients administered neoadjuvant chemotherapy could be enrolled into an enhanced recovery after surgery program for locally advanced gastric cancer[J]. Chin Med J (Engl), 2018,131(4):413-419. DOI: 10.4103/0366-6999.225047. |
[11] | Gao R, Yang H, Li Y , et al. Enhanced recovery after surgery in pediatric gastrointestinal surgery[J]. J Int Med Res, 2019,47(10):4815-4826. DOI: 10.1177/0300060519865350. |
[12] | Wisely JC, Barclay KL . Effects of an enhanced recovery after surgery programme on emergency surgical patients[J]. ANZ J Surg, 2016,86(11):883-888. DOI: 10.1111/ans.13465. |
[13] | Liu G, Jian F, Wang X , et al. Fast-track surgery protocol in elderly patients undergoing laparoscopic radical gastrectomy for gastric cancer: a randomized controlled trial[J]. Onco Targets Ther, 2016,9:3345-3351. DOI: 10.2147/OTT.S107443. |
[14] | Bu J, Li N, Huang X , et al. Feasibility of fast-track surgery in elderly patients with gastric cancer[J]. J Gastrointest Surg, 2015,19(8):1391-1398. DOI: 10.1007/s11605-015-2839-7. |
[15] | Li B, Liu HY, Guo SH , et al. Impact of early postoperative enteral nutrition on clinical outcomes in patients with gastric cancer[J]. Genet Mol Res, 2015,14(2):7136-7141. DOI: 10.4238/2015.June.29.7. |
[16] | Shimizu N, Oki E, Tanizawa Y , et al. Effect of early oral feeding on length of hospital stay following gastrectomy for gastric cancer: a Japanese multicenter, randomized controlled trial[J]. Surg Today, 2018,48(9):865-874. DOI: 10.1007/s00595-018-1665-4. |
[17] | Herbert G, Perry R, Andersen HK , et al. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications[J]. Cochrane Database Syst Rev, 2019, 7: CD004080. DOI: 10.1002/14651858.CD004080.pub4. |
[18] | Jeong O, Kim HG . Implementation of enhanced recovery after surgery (ERAS) program in perioperative management of gastric cancer surgery: a nationwide survey in Korea[J]. J Gastric Cancer, 2019,19(1):72-82. DOI: 10.5230/jgc.2019.19.e3. |
[19] | Fumagalli Romario U, Weindelmayer J, Coratti A , et al. Enhanced recovery after surgery in gastric cancer: which are the main achievements from the Italian experience?[J]. Updates Surg, 2018,70(2):257-264. DOI: 10.1007/s13304-018-0522-8. |
[20] | Elhassan A, Ahmed A, Awad H , et al. The evolution of surgical enhanced recovery pathways: a review[J]. Curr Pain Headache Rep, 2018,22(11):74. DOI: 10.1007/s11916-018-0727-z. |
[21] | Francis NK, Walker T, Carter F , et al. Consensus on training and implementation of enhanced recovery after surgery: a delphi study[J]. World J Surg, 2018,42(7):1919-1928. DOI: 10.1007/s00268-017-4436-2. |
[22] | Gianotti L, Fumagalli Romario U, De Pascale S , et al. Association between compliance to an enhanced recovery protocol and outcome after elective surgery for gastric cancer. results from a western population-based prospective multicenter study[J]. World J Surg, 2019,43(10):2490-2498. DOI: 10.1007/s00268-019-05068-x. |
[1] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[2] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[3] | Xie Shuping, Sun Yahong, Wang Chao.Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 157-165. |
[4] | Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 175-180. |
[5] | Shao Huifang, Wang Xuehong, Lu Yongfu.Mechanism of action and clinical significance of CST1 in the progression of gastric cancer[J]. Journal of International Oncology, 2023, 50(8): 489-492. |
[6] | Zhu Siyu, Wang Xuehong, Li Wenqian, Liu Shu.Level of serum FABP1 and its relationship withHelicobacter pyloriinfection in patients with gastric cancer[J]. Journal of International Oncology, 2023, 50(6): 336-341. |
[7] | Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207. |
[8] | Ji Wei, Guan Quanlin, Chen Yarui, Jiao Fuzhi, Luo Qianwen.Correlation between blood lipid level and gastric cancer[J]. Journal of International Oncology, 2023, 50(3): 183-185. |
[9] | Fan Shanlin, Wang Pinxiu, Kong Fei, Zhou Yujie, Yuan Wenzhen.Progress in the study of predictors of tumor regression grade after neoadjuvant chemotherapy for gastric cancer[J]. Journal of International Oncology, 2023, 50(2): 112-116. |
[10] | Yang Jun, Li Rong, Zeng Jianchang.Clinical efficacy of Compound Kushen Injection combined with SOX regimen in the treatment of elderly patients with advanced gastric cancer[J]. Journal of International Oncology, 2023, 50(2): 82-86. |
[11] | Deng Lili, Duan Xingyu, Li Baozhong.Advances of anti-HER2 targeted drugs and combined therapeutic regimens for gastric and esophagogastic adenocarcinoma[J]. Journal of International Oncology, 2023, 50(12): 751-757. |
[12] | Li Jiayi, Wang Yue, Shang Lanlan, Xu Xing, Zhao Yan.Practice and prospect of artificial intelligence in diagnosis and treatment of gastric cancer[J]. Journal of International Oncology, 2023, 50(11): 677-682. |
[13] | Yu Xiaopeng, Feng Qingqing, Zhao Wenfei, Zhao Wenwen, Wei Hongmei.Application of targeted therapy combined with immune checkpoint inhibitors in the treatment of HER2 positive advanced gastric cancer[J]. Journal of International Oncology, 2023, 50(10): 631-635. |
[14] | Tang Lin, Xiang Mingyue, Zhang Jianbo, Wang Lili, Gong Heyi, Han Dali.Clinical efficacy and safety of camrelizumab combined with apatinib and chemotherapy as second-line or later therapy in the treatment of HER-2 negative advanced gastric cancer[J]. Journal of International Oncology, 2022, 49(5): 276-281. |
[15] | Liu Cantong, Huang Xinyi, Chen Liuyi, Chen Hao, Peng Yuhui, Huang Xuchun.Level and diagnostic value of serum insulin-like growth factor binding protein 7 in patients with gastric cancer[J]. Journal of International Oncology, 2022, 49(12): 724-728. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||